Qi Swap Price, La Vie En Rose Piano And Voice, Morecambe Score Today, Halloween Costumes History, Ios Remote Exploit, Monolithic Vs Microkernel Vs Hybrid Kernel, " />
Site Overlay

animal research vaccine development

In fact, many of today's vaccines are based on utilizing animal pathogens, either in the form of an attenuated vaccine or as a vaccine vector. For example, animal research was vital in the development and production of the smallpox vaccine which eventually led to its eradication in 1980; until then, smallpox killed between 300-500 million people in its 12,000-year existence. Despite this fact, there are strong interests and ongoing efforts to reduce the use of animals in vaccine development. Top. To support its solutions, a strong regulatory framework is required to oversee pharmaceutical companies, including on the use of animals in research, development, and production. Peiris JS, Guan Y, Yuen KY. Human-animal chimeras, developed with a 'humanized' immune system could be … Examples of HIV research using animals. 1996;86:3-10. Was it possible to skip some of the stages that have historically required animals in order to speed things up? Though this vaccine yielded poor results, two more decades of research paved the way for the development of vaccines by Jonas Salk in 1953, and Albert Sabin in 1956. And as models of human diseases, NHPs have failed for Alzheimer’s and Parkinson’s diseases, neuroscience/brain research, stroke, cancer, hepatitis C, and many more. Animal research benefits not only humans, but also the animals themselves. In the case of COVID vaccine research, test monkeys have been infected with the virus in controlled settings where researchers have monitored how the animals… A multitude of research efforts focuses on the improvement … https://www.worldatlas.com/articles/8-animals-used-in-vaccine-production.html Animal research raises dilemmas … Scientists conducted the basic research that’s at the foundation of every COVID-19 vaccine in animals. THE Pfizer and Moderna vaccines may help guard against future viruses from animals, according to new research. ... director of NIAID’s vaccine research center, told Stat News. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. This technology has implications for many diseases beyond COVID-19. A list of some 350 animal diseases with a human counterpart has been compiled by the vet Charles CorneliusANCHOR, and a section on "Animal Disease" in Encyclopaedia Britannica contains an abbreviated list of 100 diseases common to animals and man. Hardly. Many more are on the way. However, standard lab … For instance, animals, such as dogs and cats are living longer and healthier lives thanks to vaccines for rabies, parvo virus, tetanus and feline leukemia, among other breakthroughs made in Veterinary medicine thanks to animal research. The next round of vaccines also has its roots in research in monkeys. The pre-clinical stage involves animal testing and may take an additional 1-2 years. The speed with which coronavirus research has moved is a tribute to the ingenuity of scientists, the potential of public-private partnerships and some unsung heroes: lab animals. Vaccine development has become increasingly complex with chronic and newly emerging diseases, a demand for therapeutic vaccines for noninfectious diseases, extended vaccine in the neonate and the elderly… Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease. Tuberculosis vaccine development is one important example of the complexities involved in the use of animal … Scientists conducted the basic research that’s at the foundation of every COVID-19 vaccine in animals. Over the past 100 years, animal infectious disease research has played a crucial role in the development of human vaccines. Laboratory animals treated with the new vaccines produced high blood concentrations of anti-drug antibodies and exhibited sharply reduced behavioral responses to the drugs. For instance, animals, such as dogs and cats are living longer and healthier lives thanks to vaccines for rabies, parvo virus, tetanus and feline leukemia, among other breakthroughs made in Veterinary medicine thanks to animal research. What is HIV? DOI PubMed. Herein, we present a review of influenza virus … Although the … References. Approaches to vaccine development. More than 90 percent of drugs that appear to be safe and effective in animals fail in human trials. In addition, diagnostic techniques such as scanners, and surgical techniques - to treat injuries or remove tumours for instance - are used in veterinary practice just as they are in human medicine. This page leads to other pages that describe vaccine development and testing such as basic research, clinical studies, side effects and adverse reactions, vaccines of the future, and the vaccine product approval process. ORIGINALLY PUBLISHED FEB 04, 2021 AT 6:00 AM. Now, we’re moving toward overcoming the pandemic. According to the researchers, only 2 out of 8 animals that received prime-boost intranasal administration had detectable viral RNA in nasal-wash and oral swab samples three days after getting the dose as compared to 6 out of 8 animals via the intramuscular route. Illnesses such as cancer, heart disease, asthma and malaria are suffered by many species and can be treated in much the same way. More than 32 million doses of coronavirus vaccine have been administered in the United States, according to Feb. 3 data from the Centers for Disease Control and Prevention. Animal tests normally constitute a critical step in vaccine development. The human polio vaccine was developed thanks to animal experiments and has been used to protect chimpanzees in the wild.Human and other animals suffer from many of the same diseases because, under the skin, they are very similar. The first stages are exploratory and involve basic laboratory research. Treatments for people and animalsControlling animal diseases by vaccination. Research, development and production of medicines and vaccines continue to progress toward better adapted, safer and higher quality health solutions for patients. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus … The general stages of the development cycle of a vaccine are: Exploratory stage; Pre-clinical stage In September, the vaccine started preclinical trials on pigs in Spain, funded by the European Commission's TRANSVAC2 vaccine development network. They were British drug firm AstraZeneca’s vaccine, which just received authorization in the United Kingdom, first proved itself in preclinical trials in monkeys at the University of Oxford. And just last month, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said that the Food and Drug Administration could soon approve two more vaccine candidates. Researchers have been investigating adenovirus vaccines in nonhuman primates for years in hopes of developing an easily modifiable template for fighting just about any pathogen. In recent years, the field of vaccines for diseases such as Human Immunodeficiency Virus (HIV) which take a heavy toll in developing countries has faced major failures. Hartung points to the slow trajectory of drug and vaccine development using animal modelling. R&I has led to the development of novel, highly sophisticated technologies, one example being marker vaccines. A huge range of vaccines has been developed to protect our pets, farm animals, working animals and  animals in the wild, saving millions of animal lives every year and preventing much suffering.Just as in medical research for human diseases, a lot of studies can be done on cells and tissues and using high-tech equipment. Each vaccine under development must first undergo screenings and evaluations to determine which antigen should be used to invoke an immune response. The use of vaccines is still the most effective and powerful option in the prevention of animal and human diseases. For example, animal research was vital in the development and production of the smallpox vaccine which eventually led to its eradication in 1980; until then, smallpox killed between 300-500 million people in its 12,000-year existence. Methods of treatment, such as natural or synthetic antigens, are identified; this process may take an average of 2-4 years. At first, the experiment seemed successful as all the animals developed a robust antibody response to coronavirus. Scientists are developing mRNA-based Zika and flu vaccines. Claims that COVID-19 vaccines are “experimental”, have skipped animal testing and have not completed initial research trials are false. Learn More, Animal research crucial in COVID-19 vaccine development | Commentary by MATTHEW R. BAILEY, Updated COVID-19 Health and Safety Requirements for Veterinarians in New Jersey, The Latest COVID-19 Victims: Mink and Mink Farmers, The essential role of animal studies in expediating medical research to battle the COVID-19 pandemic, How Covid-19 Has Gotten More Animal Owners To Consider Creating Pet Trusts, Telemedicine for Veterinary Practices during COVID-19. 1996;86:3-10. One specific challenge is that supply meets demand, which will often mean the new vaccine needs to be produced in large quantities. His primary research interests include development of vaccines and therapeutic agents against SARS-CoV and HIV. The way forward. drug abuse and vaccine development. Work on adenovirus vaccines that would inoculate against HIV, influenza, and several other viruses is underway. ... director of NIAID’s vaccine research center, told Stat News. Vaccine development has an even higher failure rate. Before a vaccine can be tested in people, a company or researcher performs additional laboratory research and testing in animals to obtain information about how the vaccine … To understand the structure of Animal Anti Rabies Vaccine … Snijder EJ, … For instance, distemper - which can kill dogs, seals and dolphins - is prevented by a vaccine developed using dogs in the 1920s. Information gathered is … In April 2018, global animal health company Zoetis began constructing a new animal vaccine manufacturing and research facility in Suzhou, China. Commentary on Animal Law and Legal Issues, ORIGINALLY PUBLISHED FEB 04, 2021 AT 6:00 AM. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. Vaccine development. It states: "... it is likely that, for every known human disease, an identical or similar disease exists in at least one other species".One result is that nearly 90% of the veterinary medicines that are used to treat animals are the same as, or very similar to, those developed to treat human patients. Different facilities are required to make each new vaccine, and plans will be prepared to have these ready to start production as soon as regulatory approval is … Animal tests normally constitute a critical step in vaccine development. Moreover, overriding interfering maternal antibodies is another goal for influenza vaccines in order to permit effective immunization of piglets at an early age. Pharmaceutical manufacturers are churning out hundreds of millions of doses. Animal research was instrumental in that effort — and will be behind the next miracle medical science brings about. To support its solutions, a strong regulatory framework is required to oversee pharmaceutical companies, including on the use of animals in research, development, and production. After the pandemic hit, researchers first … The STEP and Phambili MRK-Ad5 vaccine trials. They build on the work of two University of Pennsylvania scientists who discovered over two decades ago that messenger RNA-based vaccines could initiate the creation of disease-fighting proteins in mice. Methods of treatment, such as natural or synthetic antigens, are identified; this process may take an average of 2-4 years. Author C F Hendriksen 1 ... Conversely, diphtheria was one of the first diseases where experimental animal research laid the foundation for effectively reducing child mortality. Development and use of anti-retroviral medication. NIDA-supported vaccine developers have achieved promising preclinical results with novel formulations against cocaine and heroin. Over the past 100 years, animal infectious disease research has played a crucial role in the development of human vaccines. Likewise, nearly forty years of research using monkeys, rats, and mice led to the introduction of the polio vaccine in the 1950s that has since saved … A typical vaccine development timeline takes 5 to 10 years, and sometimes longer, to assess whether the vaccine is safe and efficacious in clinical trials, complete the regulatory approval processes, and manufacture sufficient quantity of vaccine doses for widespread distribution. Human-animal chimeras, developed with a 'humanized' immune system could be useful to study infectious diseases, including many neglected diseases. An experimental vaccine is first tested in animals to evaluate its safety and potential to prevent disease. Animal research benefits not only humans, but also the animals themselves. Vaccine development is characterised by a high failure rate – often 93% between animal studies and registration of a product.” The discovery and research phase is normally two-to-five years, according to the Wellcome Trust. The second stage defined relevant themes on which to focus vaccine research and development for priority pathogens and diseases. European regulators approved Johnson & Johnson’s adenovirus vaccine against Ebola in July. drug abuse and vaccine development. Early research to assess vaccine efficacy using COVID‑19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicates a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures. Consider how these vaccines came to be. And as models of human diseases, NHPs have failed for Alzheimer’s and Parkinson’s diseases, neuroscience/brain research, stroke, cancer, hepatitis C, and many more. More than 90 percent of drugs that appear to be safe and effective in animals fail in human trials. Almost all human diseases exist in at least one other species. It also analyzes key emerging trends and their impact on present and future development. For instance, distemper … The development of drugs and medical technologies that help to reduce suffering among humans and animals depends on the carefully regulated use of animals for research. Each vaccine under development must first undergo screenings and evaluations to determine which antigen should be used to invoke an immune response. In the 1950s, scientists distinguished varicella from herpes zoster (shingles), and subsequent research lead to the development of first vaccine for chickenpox in Japan in the 1970s. At present, there are many obstacles and challenges to vaccine research and development, including the lack of knowledge about virus transmission, pathogenesis, and … Research, development, and production of vaccines are still highly dependent on the use of animal models in the various evaluation steps. The new mRNA technology targets specific MS-related proteins without compromising normal immune function. Early human SARS-CoV is closer genetically to animal SARS-CoV–like virus than to ... New York Blood Center. The development of drugs and medical technologies that help to reduce suffering among humans and animals depends on the carefully regulated use of animals for research. Different strategies are under development to produce vaccines that provide better cross-protection for swine. FDA’s scientific and regulatory advice to vaccine developers, as well as FDA’s evaluation to determine the safety and effectiveness of … Then, with the permission of regulators, they tested the candidates for efficacy simultaneously in humans and animals. However, standard lab … In the 21st century scientists are continuing to work on treatments for cancer, stroke, heart disease, HIV, malaria, tuberculosis, diabetes, neurodegenerative diseases like Alzheimer's and Parkinson’s, and very … A short history of the use of animals in vaccine development and quality control Dev Biol Stand. In order to gain a more complete understanding of these interactions, we identify and characterize the bacterial gene products that are required to establish infection and cause disease. NIDA-supported vaccine developers have achieved promising preclinical results with novel formulations against cocaine and heroin. If the vaccine triggers an immune response, it is then … These latter two vaccines inject recipients with an adenovirus containing DNA with instructions for building the spike protein that rings the coronavirus. It’s remarkable that scientists have been able to develop effective vaccines for COVID-19 within months. Animal research animal testing are of course vital in the development of medicines to treat animals. They suggest the potential for intranasal administration as a way to further improve the efficacy of this leading vaccine … A vaccine designed to protect a particular animal species must be shown to be effective and safe that species before it can be used by vets. This preclinical phase is done without testing on humans. Severe acute respiratory syndrome. The two vaccines currently authorized for use in the United States — developed by Moderna and a partnership between Pfizer and German firm BioNTech — were first determined effective in rhesus macaques. Research objectives To study and analyze the global Animal Anti Rabies Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025. Nat Med. This massive vaccination campaign is happening less than a year after health officials confirmed the first known case of the virus on U.S. soil. However, when the scientists exposed the vaccinated animals to the wild virus, the results were horrifying. By applying AI to the vaccine development process, the companies hope to predict adverse neurovirulent side effects resulting from vaccinations, reducing the reliance on animal testing in the process. At the end of the 19th century, several vaccines for humans had been developed. This is in response to emerging needs and opportunities. The new facility will house a global manufacturing and supply facility, as well as a research and development (R&D) centre. Traditional … Animal research raises dilemmas … Conversely, diphtheria was one of the first diseases where experimental animal research laid the foundation for effectively reducing child … Like the development of vaccines, manufacturing is highly complex and takes time. In addition, w… Oxford University confirmed the vaccine it created with AstraZeneca has undergone animal trials in the UK, US and Australia (here). Animal testing has become an important stage in vaccine development. The vaccines developed by Moderna and the Pfizer-BioNTech team utilize a different approach. Ever since the development of the first vaccine more than 200 years ago, vaccinations have greatly decreased the burden of infectious diseases worldwide, famously leading to the eradication of small pox and allowing the restriction of diseases such as polio, tetanus, diphtheria, and measles. Experts say current mRNA Covid-19 jabs may already offer some protection against kille… Laboratory animals treated with the new vaccines produced high blood concentrations of anti-drug antibodies and exhibited sharply reduced behavioral responses to the drugs. Cutting-edge research and development of safe, high-efficacy, high-quality vaccines means that pets and farm animals remain able to benefit from crucial medicines which may prevent or alleviate the clinical signs and stages of disease. https://www.novartis.com/.../transparency-disclosure/animals-research Animals benefit from the medicines developed initially for people - such as antibiotics, anaesthetics, antiparasitics and insulin for diabetes - but treatments specifically for animal diseases have also been developed. More than 125 potential vaccines are in development some seven months after the world first learned of the coronavirus. Developing and Evaluating Animal Models for Studying the Safety and Efficacy of Vaccines Against Anthrax, Staphylococcal Infections, and Pertussis Biologics Research Projects Canada's research community and vaccine industry consider these themes when creating their specific innovation strategies and work plans. But animals are still needed to find out what happens in the whole living body. This research – the first of its kind for the novel coronavirus – aims to support the pandemic response by aiding the development of vaccines and treatments. Animals benefit from the medicines developed initially for people - such as antibiotics, anaesthetics, antiparasitics and insulin for diabetes - but treatments specifically for animal diseases have also been developed. This review discusses human vaccine candidates in any stage of development and explores the viral characteristics, molecular epidemiology, and immunology associated with CoV vaccine development. Maryland-based Novavax, whose shot is in phase 3 clinical trials in humans, reported in July that the mice and non-human primates that received its vaccine developed an immune response after the first dose. The vaccines were evaluated for immunogenicity and efficacy; however, because of the previous report of immunopathology on challenge of ferrets and nonhuman primates that had been vaccinated with a whole virus adjuvanted vaccine and mice that had been vaccinated with a VLP vaccine, the primary orientation was to assess for immunopathology among animals in relation to type of vaccine… To ensure participants’ safety, they will be monitored constantly and scientists will infect them with a version of the virus that’s been shown to pose a low risk to young, healthy adults. Many more are on the way. In the 21st century scientists are continuing to work on treatments for cancer, stroke, heart disease, HIV, malaria, tuberculosis, diabetes, neurodegenerative diseases like Alzheimer's and Parkinson’s, and very … Animal research crucial in COVID-19 vaccine development | Commentary by MATTHEW R. BAILEY. Clive Dix, PhD, interim … References. Likewise, nearly forty years of research using monkeys, rats, and mice led to the introduction of the polio vaccine in the 1950s that has since saved … A few hundred dogs were used in that research programme, with the result that the UK's seven-million pet dog population is now protected from distemper. Vaccine development. The pre-clinical stage involves animal testing and may take an additional 1-2 years. Once the body produces this foreign antigen, the immune system recognizes it and produces antibodies against it. More than 32 million doses of coronavirus vaccine have been administered in the United States, according to Feb. 3 data from the Centers for Disease Control and Prevention. 2004; 10: S88 – 97. This preclinical phase is done without testing on humans. Existing treatments for MS suppress the immune system and consequently leave patients vulnerable to infection. This website uses cookies to improve your experience. This had a very profound impact on the attitude of society towards animal experiments in … By continuing to browse our website you consent to our use of cookies as set forth in our Cookie Policy. Animal testing has become an important stage in vaccine development. The vaccine successfully alleviated symptoms in sick mice and prevented progression in those showing early signs of the disease. Teams of US & foreign scientists vaccinated animals with the four most promising vaccines. Our laboratory is studying the interaction between humans and three important bacterial pathogens, Bordetella pertussis (causes whooping cough), Bacillus anthracis (anthrax), and Staphylococcus aureus (causes skin disease, "blood poisoning," toxic shock syndrome). Animal models of HIV. For that, we can thank animal research. In fact, many of today's vaccines are based on utilizing animal pathogens, either in the form of an attenuated vaccine or as a vaccine vector. Much research is done to protect animals from diseases, particularly by vaccination. Some critics of animal research have wondered how scientists could have developed the COVID-19 vaccine in less than a year when previous vaccines took decades to bring to market. In April 2018, global animal health company Zoetis began constructing a new animal vaccine manufacturing and research facility in Suzhou, China. If the vaccine triggers an immune response, it is then … These mRNA vaccines introduce a sequence of mRNA that codes for a disease-specific antigen into the body’s cells. The vaccine candidate Johnson & Johnson developed — which, in contrast to the others, only requires one dose — is the product of research in rhesus macaques, too. These would also serve as an important tool for the efficient testing of new vaccine candidates to streamline promising candidates for further trials in humans. As a contract research organization (CRO), Wageningen Bioveterinary Research (WBVR) develops vaccines against viral and bacterial diseases together with our public and private clients. Animal research made possible drugs that keep HIV/AIDS at bay, and has set the stage for a vaccine. Matthew R. Bailey is president of the Foundation for Biomedical Research, a Washington, D.C.-based nonprofit that promotes ethical animal research. We can thank animal research for that. Novavax developed a novel MERS coronavirus vaccine candidate in 2013 which is a crucial target for coronavirus vaccine development Novavax, which has robust vaccine technology platforms, has produced and is currently assessing multiple recombinant nanoparticle vaccine candidates in animal models prior to advancing to clinical trials.

Qi Swap Price, La Vie En Rose Piano And Voice, Morecambe Score Today, Halloween Costumes History, Ios Remote Exploit, Monolithic Vs Microkernel Vs Hybrid Kernel,

Leave a Reply

Your email address will not be published. Required fields are marked *

SUPPORT YOUR

The NAACP has always been at the forefront of the fight against racial discrimination and economic inequality. Voting rights and the battles against voter suppression are just as important today as they were during the Civil Rights Movement. Health care, education, and economic opportunity need our action if they are ever to improve.

Help us win the fight.

ACT-SO Committee

underline

ACT-SO (Afro-Academic, Cultural, Technological and Scientific Olympics) honors academic and cultural achievers at the same level as sports achievers. ACT-SO members recruit 9th through 12th grade students annually for an academic competition. The NAACP believes that African-Americans can succeed and compete at the same or superior levels as their counterparts in classrooms, boardrooms and laboratories throughout the world.

Chair: Avelina Holmes

Meeting Date & Time: Varies according to ACT-SO activity schedule

actso@naacphouston.org

Armed Services & Veterans Affairs Committee

underline

The Armed Services and Veterans Affairs Committee focuses on Armed Services and Veterans programs at the local, state and national levels to ensure they are administered fairly for minorities. The committee studies conditions pertaining to minorities and their families and handles discrimination complaints from members of the Armed Services and Veterans.

Chair: W. Clyde Lemon

Date & Time: 1st Monday, 12:00 pm via conference call

veterans@naacphouston.org

Communications Press & Publicity Committee

underline

The Communications Press & Publicity Committee works to eliminate employment segregation and discrimination in the media industry. The members monitor local and national media including advertising, and promote the NAACP Houston Branch to gain favorable publicity in local newspapers, television and other media.

Chair: Linda Chandler Jacobs

Meeting Date & Time: TBD 2nd Tuesday 6:30pm @ NAACP

media@naacphouston.org

Community Coordination Committee

underline

The Committee on Community Coordination enlists the support of other community organizations on issues affecting the interests of minority groups and the NAACP Houston Branch in order to increase membership and volunteer recruitment, build coalitions around common goals, and increase Freedom Fund sponsorship of and attendance.

Meeting Chair: Juli McShay

Date & Time: First Monday of the Month, 4:30 p.m.

community@naacphouston.org

Criminal Justice Committee

underline

The Committee on Criminal Justice raises awareness about the inequities in the criminal and juvenile justice systems as well as some of the public misconceptions about the impact of recent “get tough” criminal policies on crime rate trends. Member work to increase minority participation in the Grand Jury system.

Chair: James Dixon, II

Meeting Date & Time: 1st Tuesday 6:30pm @ NAACP

justice@naacphouston.org

Economic Development Committee

underline

The Economic Development Committee implements local efforts and supports national programs that preserve and expand economic empowerment among minorities. The members promote business and home ownership, employment, and job creation.

Chair: Roger Harris

Meeting Date & Time: 2nd Monday 5:30pm @ NAACP

economics@naacphouston.org

Education Committee

underline

The Education Committee works to eliminate segregation and other discriminatory practices in public education. Members focus on educational conditions affecting minorities including dropout rates, school funding, attendance, parental involvement, standardized testing, and teacher certification.

Chair: Dr. Carolyn Evans -Shabazz

Meeting Date & Time: 1st Thursday 6:00pm @ NAACP

education@naacphouston.org

Environmental Climate Justice Committee

underline

The Environmental and Climate Justice Committee raises awareness of environmental issues, climate change and energy reform policies, and the linkages between environmental quality and social justice. The members are active in the Coalition for Environment, Equity, and Resilience (CEER), a collaborative made up of nonprofit organizations who have committed to working together to advance an 8 point plan.

Chair: Jacqueline Smith

Meeting Date & Time: Meeting times vary according to the Environmental Climate activity schedule.

climate@naacphouston.org

Freedom Fund Committee

underline

The Freedom Fund Committee (FFC) is the fundraising arm for the NAACP Houston Branch. The Annual Freedom Fund Advocacy and Awards Dinner (FFAAD) is the primary fundraiser for the branch. The FFAAD is traditionally held on the 4th Friday of October. Proceeds from the event support the branch operations and advocacy programming for the branch. The FFC also assists the unit with securing funds for special advocacy projects and the capital improvement fund for the branch headquarters.

Chair: Argentina M. James

Meeting Date & Time: Varies according to Freedom Fund activity schedule.

freedomfund@naacphouston.org

Health Committee

underline

The Health Committee is concerned with access to health care, health education, treatment and research, and sponsors health fairs and workshops highlighting important health issues for minorities.

Chair: Carol Moore

Meeting Date & Time: Varies according to Health activity schedule.

health@naacphouston.org



Housing Committee

underline

The Housing Committee studies housing conditions and new financing methods to promote home ownership. The members oppose all restrictive practices whether public or private, and refer complaints of housing discrimination.

Chair: Belinda Everette

Meeting Date & Time: 1st Wednesday 12:30 pm @ NAACP

housing@naacphouston.org

Labor & Industry Committee

underline

The Labor & Industry Committee works to eliminate discriminatory employment practices in industry and government, wage differentials based on race, unequal opportunities for training and promotion, discriminatory practices in labor unions, and unfair dismissals.

Chair: John Bland

Meeting Date & Time: 3rd Wednesday 6:00pm @ NAAC

labor@naacphouston.org

Legal Redress Committee

underline

The Legal Redress Committee on Legal Redress investigates all cases reported to the NAACP Houston Branch, supervise all litigation in which the Branch is involved, and keeps the National NAACP and Branch informed on the progress of every case.

Co-Chair: Mary King, Esq. & Charles Livingston, Esq.

Legal Clinics: 3rd Saturday of each month, 9am-2pm

legalredress@naacphouston.org

Membership & Life Membership Committee

underline

The Membership & Life Membership Committee works to increase membership by organizing campaigns, soliciting new members and renewals, and encouraging life memberships.

Chair: Mable Caleb

Meeting Date & Time: TBD 2nd Tuesday 5:30pm @ NAACP

membership@naacphouston.org

Political Action Committee

underline

The Political Action Committee focuses on voter registration and election turnout as well as legislation designed to improve the educational, political and economic status of minority groups. Members monitor proposed legislation and seeks the repeal of racially discriminatory laws. The Committee is non-partisan and does not endorse candidates for public office.

Chair: Claude Cummings Jr.

Meeting Date & Time: 2nd Monday 6:00pm @ NAACP

PAC-GOTV@naacphouston.org

Religious Affairs Committee

underline

The Religious Affairs Committee uses an educational program designed to give moral and ethical interpretation to the civil rights struggle and conveys this message to religious groups of all faiths. Members seek the support of religious groups for membership and fund raising.

Chair: Bishop Johnny Tates

Meeting Date & Time: TBD

religion@naacphouston.org

WIN (Women In the NAACP) Committee

underline

The WIN Committee supports social justice issues affecting women by serving as an advocacy vehicle for social, economic, political, educational and health and welfare issues affecting women.

Co-Chair: Sylvia Donahue- McCarter

Meeting Date & Time: 2nd Wednesday 6:30pm @ NAACP

WIN@naacphouston.org

Young Adult Committee

underline

The Young Adult Committee works with the Membership Committee to solicit memberships of individuals 21-40 years of age, and maintain a mentorship program that is a support bridge from youth and college to NAACP Houston Branch participation. Also provide networking and social opportunities for young adults.

Chair: Porschia Harris & Cha’Mira Keener

Meeting Date & Time: 1st Thursday 6:30pm @ NAACP

youngadult@naacphouston.org

Youth Works Committee

underline

The Youth Works Committee collaborates with the national NAACP to recognize exemplary youth, develop programs and activities consistent with the Association’s policies and mission for youth groups.

Chair: Avelina Holmes

Meeting Date & Time:Varies according to ACT-SO activity schedule

youthworks@naacphouston.org